Advertisement

Advertisement

NCCN 2020 Virtual Congress: Hematologic Malignancies

Leukemia

By Alice Goodman  / November 10, 2020  / NCCN 2020 Virtual Congress: Hematologic Malignancies

Chronic Lymphocytic Leukemia: New Treatments Achieve Deeper Remissions

At the National Comprehensive Cancer Network® (NCCN®) 2020 Virtual Congress: Hematologic Malignancies, William Wierda, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, reviewed ...

Lymphoma
Immunotherapy

By Alice Goodman  / November 10, 2020  / NCCN 2020 Virtual Congress: Hematologic Malignancies

Do All Patients With Refractory Diffuse Large B-Cell Lymphoma Need CAR T-Cell Therapy?

Chimeric antigen receptor (CAR) T-cell therapy has made great strides in treating patients with relapsed or refractory diffuse large-B cell lymphoma (DLBCL) and refractory mantle cell lymphoma (MCL), ...

Advertisement

Advertisement




Apr
26
Today In Oncology
FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs
AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer
In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer
Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved
Potential Protective Effects of Aspirin Against Colorectal Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside